Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02606305
What this trial is testing

Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
ImmunoGen, Inc. 264
Testing effectiveness (Phase 2)Study completedNCT03470805
What this trial is testing

Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma

Who this might be right for
Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario 9
Early research (Phase 1)Study completedNCT01445418
What this trial is testing

AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Testing effectiveness (Phase 2)Study completedNCT04387227
What this trial is testing

Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
University of Washington 22
Testing effectiveness (Phase 2)Study completedNCT01720173
What this trial is testing

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Gynecologic Oncology Group 30
Early research (Phase 1)Ended earlyNCT06457997
What this trial is testing

PHN-010 in Patients With Advanced Solid Tumors

Who this might be right for
Lung CancerColon CancerEndometrial Cancer+4 more
Pheon Therapeutics 26
Not applicableStudy completedNCT01346761
What this trial is testing

Risk Education and Assessment for Cancer Heredity

Who this might be right for
Breast CancerOvarian CancerGenetic Predisposition
University of Utah 1,012
Early research (Phase 1)Looking for participantsNCT07733505
What this trial is testing

Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Women With Advanced Ovarian Cancer?

Who this might be right for
Ovarian Cancer
Odense University Hospital 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04884360
What this trial is testing

D9319C00001- 1L OC Mono Global RCT

Who this might be right for
Ovarian Cancer
AstraZeneca 366
Testing effectiveness (Phase 2)Study completedNCT00671788
What this trial is testing

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Gynecologic Oncology Group 35
Not applicableStudy completedNCT02069769
What this trial is testing

Ensuring Communication in Hospice by Oncology Study (ECHO)

Who this might be right for
Ovarian CancerCervical CancerUterine Cancer+3 more
Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT00001383
What this trial is testing

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerCancerCarcinoma, Renal Cell+2 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Ended earlyNCT05325866
What this trial is testing

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Who this might be right for
Solid Tumors
Amgen 260
Testing effectiveness (Phase 2)Ended earlyNCT00001827
What this trial is testing

P53 Vaccine for Ovarian Cancer

Who this might be right for
Ovarian Neoplasm
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableUnknownNCT04001023
What this trial is testing

Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma+1 more
Turku University Hospital 40
Not applicableUnknownNCT00154986
What this trial is testing

IGFBP-3 in Ovarian Cancer Invasion

Who this might be right for
Ovarian Carcinoma
National Taiwan University Hospital 30
Not applicableStudy completedNCT00531570
What this trial is testing

Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian Neoplasms
NYU Langone Health 100
Next Page